Citation: | HAN Long, TAN Deng, WAN Shi-wei, FANG Peng-hua, HUANG Gui-cheng, MIN Wen. The Effect of Erzhiwan on Glucose Metabolism of Adipose Tissue in Postmenopausal Osteoporosis Model Rats[J]. Journal of Nanjing University of traditional Chinese Medicine, 2022, 38(5): 419-423. doi: 10.14148/j.issn.1672-0482.2022.0419 |
[1] |
绝经后骨质疏松症(骨痿)中医药诊疗指南(2019年版)[J]. 中医正骨, 2020, 32(2): 1-13.
Guidelines for TCM diagnosis and treatment of postmenopausal osteoporosis(2019 edition)[J]. J Tradit Chin Orthop Traumatol, 2020, 32(2): 1-13.
|
[2] |
曾文泓, 王丽华, 梅鸥. 二至丸治疗绝经后肝肾阴虚型骨质疏松症的临床效果及对骨生化标志物的影响[J]. 中国医学创新, 2020, 17(11): 78-82. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYCX202011020.htm
ZENG WH, WANG LH, MEI O. Efficacy of erzhi pills on liver and kidney Yin deficiency type of postmenopausal osteoporosis and the influence in bone biochemical markers[J]. Med Innov China, 2020, 17(11): 78-82. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYCX202011020.htm
|
[3] |
程敏. 二至丸及其组方药物防治骨质疏松与作用机制研究[D]. 西安: 西北大学, 2012.
CHENG M. The study of antiosteoporotic effects and mechanisms of EZW, fructus ligustri lucidi and herba ecliptae on osteoporosis[D]. Xi'an: Northwest University, 2012.
|
[4] |
闵愈, 袁德培, 胡玉萍, 等. 二至丸干预去卵巢骨质疏松大鼠骨重建的效应及机制[J]. 南京中医药大学学报, 2020, 36(2): 215-220. https://www.cnki.com.cn/Article/CJFDTOTAL-NJZY202002018.htm
MIN Y, YUAN DP, HU YP, et al. Effect of erzhi wan on bone metabolism in rats with ovariectomized osteoporosis[J]. J Nanjing Univ Tradit Chin Med, 2020, 36(2): 215-220. https://www.cnki.com.cn/Article/CJFDTOTAL-NJZY202002018.htm
|
[5] |
邓雪. 二至丸有效成分调控骨重建的作用机制研究[D]. 大连: 大连医科大学, 2019.
DENG X. Study on the mechanism of active components of Er-Zhi-wan in regulating bone remodeling[D]. Dalian: Dalian Medical University, 2019.
|
[6] |
李平, 林煜, 陈翔, 等. 二至丸提取物干预去势骨质疏松雌性模型大鼠的骨重建特点[J]. 中国组织工程研究, 2021, 25(2): 191-195. https://www.cnki.com.cn/Article/CJFDTOTAL-XDKF202102008.htm
LI P, LIN Y, CHEN X, et al. Characteristics of bone remodeling in female ovariectomized rat models of osteoporosis undergoing Erzhi Pill extract intervention[J]. Chin J Tissue Eng Res, 2021, 25(2): 191-195. https://www.cnki.com.cn/Article/CJFDTOTAL-XDKF202102008.htm
|
[7] |
张立智, 蒋垚. 骨免疫学研究进展[J]. 国际骨科学杂志, 2009, 30(4): 218-220, 235. https://www.cnki.com.cn/Article/CJFDTOTAL-GWGK200904004.htm
ZHANG LZ, JIANG Y. Advances in bone immunology[J]. Int J Orthop, 2009, 30(4): 218-220, 235. https://www.cnki.com.cn/Article/CJFDTOTAL-GWGK200904004.htm
|
[8] |
韩龙, 万仕炜, 王睿, 等. 脂肪因子与绝经后骨质疏松症关系研究进展[J]. 生命的化学, 2018, 38(4): 524-528. https://www.cnki.com.cn/Article/CJFDTOTAL-SMHX201804004.htm
HAN L, WAN SW, WANG R, et al. Research progress on the relationship between adipokine and postmenopausal osteoporosis[J]. Chem Life, 2018, 38(4): 524-528. https://www.cnki.com.cn/Article/CJFDTOTAL-SMHX201804004.htm
|
[9] |
鲍晓雪, 王娜, 李玉坤. 肥胖与骨质疏松症关系的研究进展[J]. 中华临床医师杂志(电子版), 2015, 9(14): 2749-2753. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLYD201514030.htm
BAO XX, WANG N, LI YK. Advances in the relationship between obesity and osteoporosis[J]. Chin J Clin Electron Ed, 2015, 9(14): 2749-2753. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLYD201514030.htm
|
[10] |
李方方, 李东阳, 赵红. 肥胖对骨质疏松症分子水平影响的研究进展[J]. 山东医药, 2014, 54(29): 106-108. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYY201429048.htm
LI FF, LI DY, ZHAO H. Research progress of molecular influence of obesity on osteoporosis[J]. Shandong Med J, 2014, 54(29): 106-108. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYY201429048.htm
|
[11] |
莫娟, 欧阳俊. 绝经后妇女肥胖与骨密度的关系[J]. 中国骨质疏松杂志, 2015, 21(7): 832-834, 854. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZS201507016.htm
MO J, OUYANG J. The relationship between obesity and bone mineral density in postmenopausal women[J]. Chin J Osteoporos, 2015, 21(7): 832-834, 854. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZS201507016.htm
|
[12] |
宫祎慧, 闫彩凤. 肥胖患者脂肪分布和代谢与骨质疏松症关系的研究进展[J]. 中华肥胖与代谢病电子杂志, 2020, 6(1): 55-57. https://www.cnki.com.cn/Article/CJFDTOTAL-FPDX202001018.htm
GONG YH, YAN CF. Research progress between fat distribution and metabolism and osteoporosis in obese patients[J]. Chin J Obes Metab Dis Electron Ed, 2020, 6(1): 55-57. https://www.cnki.com.cn/Article/CJFDTOTAL-FPDX202001018.htm
|
[13] |
邓婷, 颜玲. 雌激素对脂肪的影响研究进展[J]. 中国临床解剖学杂志, 2015, 33(2): 236-238. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLJZ201502028.htm
DENG T, YAN L. The research progress of the effects of estrogen on adipose tissue[J]. Chin J Clin Anat, 2015, 33(2): 236-238. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLJZ201502028.htm
|
[14] |
邵佳乐, 周建, 李志忠, 等. 雌激素受体信号通路与骨质疏松症相关性的研究进展[J]. 中国生物制品学杂志, 2020, 33(8): 956-960. https://www.cnki.com.cn/Article/CJFDTOTAL-SWZP202008023.htm
SHAO JL, ZHOU J, LI ZZ, et al. Progress in research on correlation of estrogen receptor signaling pathway with osteoporosis[J]. Chin J Biol, 2020, 33(8): 956-960. https://www.cnki.com.cn/Article/CJFDTOTAL-SWZP202008023.htm
|
[15] |
韩龙, 闵文, 吴铭杰, 等. 补肾通络方促进骨质疏松症大鼠骨形成机制[J]. 中国中西医结合杂志, 2019, 39(1): 97-102. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ201901027.htm
HAN L, MIN W, WU MJ, et al. Mechanism of bushen Tongluo formula in promoting bone formation in osteoporosis rats[J]. Chin J Integr Tradit West Med, 2019, 39(1): 97-102. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ201901027.htm
|